Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Influence of inhaled nicotine source on arterial stiffness.

Szołtysek-Bołdys I, Sobczak A, Zielińska-Danch W, Bartoń A, Koszowski B, Kośmider L.

Przegl Lek. 2014;71(11):572-5.

PMID:
25799846
2.

Secondhand exposure to vapors from electronic cigarettes.

Czogala J, Goniewicz ML, Fidelus B, Zielinska-Danch W, Travers MJ, Sobczak A.

Nicotine Tob Res. 2014 Jun;16(6):655-62. doi: 10.1093/ntr/ntt203. Epub 2013 Dec 11.

3.

[Water pipe smoking and psychoactive substances].

Zielińska-Danch W, Czogała J, Adamczyk R, Danch M.

Przegl Lek. 2012;69(10):921-3. Polish.

PMID:
23421061
4.

[Evaluation of changes in hemodynamic parameters after the use of electronic nicotine delivery systems among regular cigarette smokers].

Czogała J, Cholewiński M, Kutek A, Zielińska-Danch W.

Przegl Lek. 2012;69(10):841-5. Polish.

PMID:
23421044
5.

Electronic cigarette use among teenagers and young adults in Poland.

Goniewicz ML, Zielinska-Danch W.

Pediatrics. 2012 Oct;130(4):e879-85. doi: 10.1542/peds.2011-3448. Epub 2012 Sep 17.

PMID:
22987874
6.

Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking.

Goniewicz ML, Eisner MD, Lazcano-Ponce E, Zielinska-Danch W, Koszowski B, Sobczak A, Havel C, Jacob P, Benowitz NL.

Nicotine Tob Res. 2011 Mar;13(3):202-8. doi: 10.1093/ntr/ntq237. Epub 2011 Jan 21.

7.

Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.

Benowitz N, Goniewicz ML, Eisner MD, Lazcano-Ponce E, Zielinska-Danch W, Koszowski B, Sobczak A, Havel C, Jacob P 3rd.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2795-800. doi: 10.1158/1055-9965.EPI-10-0497. Epub 2010 Aug 30.

8.

Exposure to carbon monoxide from second-hand tobacco smoke in Polish pubs.

Goniewicz MŁ, Czogała J, Kośmider L, Koszowski B, Zielińska-Danch W, Sobczak A.

Cent Eur J Public Health. 2009 Dec;17(4):220-2.

9.

The role of pharmacists in smoking cessation in Poland.

Goniewicz ML, Lingas EO, Czogala J, Koszowski B, Zielinska-Danch W, Sobczak A.

Eval Health Prof. 2010 Mar;33(1):81-95. doi: 10.1177/0163278709356190. Epub 2009 Dec 29.

10.

[Relationship between nicotine dependence and smoking topography].

Zielińska-Danch W, Goniewicz MŁ, Koszowski B, Łabanowicz A, Czogała J, Szołtysek-Bołdys I, Antosiewicz B, Sobczak A.

Przegl Lek. 2010;67(10):1033-6. Polish.

PMID:
21360956
11.

[Waterpipe smoking among adolescents in Silesia region of Poland].

Mach P, Zielińska-Danch W, Goniewicz MŁ, Koszowski B, Czogała J, Sobczak A.

Przegl Lek. 2010;67(10):1021-4. Polish.

PMID:
21360953
12.

[Knowledge and attitudes toward smoke-free law among smoking and non-smoking medical students].

Zielińska-Danch W, Goniewicz MŁ, Koszowski B, Leszczyńska J, Czogała J, Szołtysek-Bołdys I, Antosiewicz B, Sobczak A.

Przegl Lek. 2010;67(10):972-5. Polish.

PMID:
21360940
13.

[Influence of smoking topography on respirabile suspended particulates concentrations in main and side stream].

Czogała J, Koszowski B, Goniewicz MŁ, Zielińska-Danch W, Sobczak A.

Przegl Lek. 2010;67(10):940-3. Polish.

PMID:
21360932
14.

Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.

Goniewicz ML, Havel CM, Peng MW, Jacob P 3rd, Dempsey D, Yu L, Zielinska-Danch W, Koszowski B, Czogala J, Sobczak A, Benowitz NL.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3421-5. doi: 10.1158/1055-9965.EPI-09-0874.

15.

[Novel risk factors for cardiovascular disease and tobacco smoke].

Sobczak A, Szołtysek-Bołdys I, Zielińska-Danch W, Grela W, Gnyp W, Koszowski B.

Przegl Lek. 2008;65(10):715-8. Polish.

PMID:
19189586
16.

[Tobacco smoke exposure levels and lipide profile].

Zielińska-Danch W, Czogała J, Sobczak A, Grela W, Gnyp W.

Przegl Lek. 2008;65(10):500-4. Polish.

PMID:
19189533
17.

[Estimation of optimal levels of tobacco biomarkers to distinguish active and passive smokers using ROC analysis].

Zielińska-Danch W, Goniewicz MŁ, Szołtysek-Bołdys I, Czogała J, Koszowski B, Słodczyk E, Anczyk E, Sobczak A.

Przegl Lek. 2009;66(10):636-40. Polish.

PMID:
20301899
18.

[Exposure to respirable suspended particles in smoking and non-smoking sections of pubs in southern Poland].

Cholewinski M, Adamczyk R, Czogała J, Goniewicz MŁ, Zielinska-Danch W, Sobczak A, Słodczyk E, Koszowski B.

Przegl Lek. 2009;66(10):628-31. Polish.

PMID:
20301897
19.

[Does tobacco smoke influence the concentration of asymmetric dimethylarginine (ADMA) in healthy males plasma?].

Sobczak A, Szołtysek-Bołdys I, Grela W, Zielińska-Danch W.

Przegl Lek. 2007;64(10):698-702. Polish.

PMID:
18409289
20.

[The influence of tobacco smoke on homocysteine level in plasma of healthy males].

Sobczak A, Szołtysek-Bołdys I, Grela W, Zielińska-Danch W.

Przegl Lek. 2007;64(10):679-84. Polish.

PMID:
18409285
21.

Estimation of urinary cotinine cut-off points distinguishing non-smokers, passive and active smokers.

Zielińska-Danch W, Wardas W, Sobczak A, Szołtysek-Bołdys I.

Biomarkers. 2007 Sep-Oct;12(5):484-96.

PMID:
17701747
22.
23.

[Biomarkers of tobacco smoke].

Sobczak A, Wardas W, Zielińska-Danch W, Szołtysek-Bołdys I.

Przegl Lek. 2005;62(10):1192-9. Review. Polish.

PMID:
16521990
24.

The influence of smoking on plasma homocysteine and cysteine levels in passive and active smokers.

Sobczak A, Wardas W, Zielinska-Danch W, Pawlicki K.

Clin Chem Lab Med. 2004 Apr;42(4):408-14.

PMID:
15147151

Supplemental Content

Loading ...
Support Center